Literature DB >> 11237717

Redox-sensitive regulation of lox-1 gene expression in vascular endothelium.

M Nagase1, K Ando, T Nagase, S Kaname, T Sawamura, T Fujita.   

Abstract

Oxidative stress has been implicated in atherosclerosis and its underlying conditions. LOX-1 is a novel endothelial receptor for oxidized low-density lipoprotein which might mediate endothelial dysfunction and subsequent atherogenesis. In the present study, we examined LOX-1 gene regulation by oxidative stress. First, superoxide anions generated by hypoxanthine and xanthine oxidase as well as hydrogen peroxide increased LOX-1 mRNA expression in cultured aortic endothelial cells. Homocysteine, an atherogenic substance believed to exert its effects through oxidative stress, enhanced endothelial LOX-1 gene expression, which was suppressed by N-acetylcysteine. Second, rats receiving angiotensin II for 10 days manifested hypertension and LOX-1 upregulation in aortic endothelium via AT1 receptor. Tempo, a superoxide dismutase mimetic, alleviated LOX-1 augmentation induced by angiotensin II. These results indicated redox-sensitive upregulation of LOX-1 mRNA in both in vitro and in vivo systems, suggesting its potential role in atherosclerosis. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11237717     DOI: 10.1006/bbrc.2001.4374

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia.

Authors:  Mehmet Balin; Ahmet Celik; M Ali Kobat
Journal:  J Thromb Thrombolysis       Date:  2012-04       Impact factor: 2.300

2.  The lectin-like oxidized low-density lipoprotein receptor and its role in atherosclerosis.

Authors:  Mehmet Cilingiroglu; Kerem Ozer
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

Review 3.  Oxidative stress and organ damages.

Authors:  Sayoko Ogura; Tatsuo Shimosawa
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

Review 4.  Reactive oxygen species: roles in blood pressure and kidney function.

Authors:  Christopher S Wilcox
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

5.  High sputum total adiponectin is associated with low odds for asthma.

Authors:  Akshay Sood; JeanClare Seagrave; Guy Herbert; Michelle Harkins; Yasir Alam; Annalisa Chiavaroli; Rugia Shohreh; Paolo Montuschi; Matthew Campen; Molly Harmon; Clifford Qualls; Marianne Berwick; Mark Schuyler
Journal:  J Asthma       Date:  2014-02-11       Impact factor: 2.515

6.  Blockade of LOX-1 prevents endotoxin-induced acute lung inflammation and injury in mice.

Authors:  Ping Zhang; Ming-Cheh Liu; Lili Cheng; Mei Liang; Hong-long Ji; Jian Fu
Journal:  J Innate Immun       Date:  2008-10-01       Impact factor: 7.349

7.  Combined effects of niacin and chromium treatment on vascular endothelial dysfunction in hyperlipidemic rats.

Authors:  N Niu; Y H Yu; Y Wang; L J Wang; Q Li; L M Guo
Journal:  Mol Biol Rep       Date:  2008-07-12       Impact factor: 2.316

8.  Homocysteine up-regulates vascular transmembrane chemokine CXCL16 and induces CXCR6+ lymphocyte recruitment in vitro and in vivo.

Authors:  O Postea; R R Koenen; M Hristov; C Weber; A Ludwig
Journal:  J Cell Mol Med       Date:  2008-01-11       Impact factor: 5.310

9.  Unveiling LOX-1 receptor interplay with nanotopography: mechanotransduction and atherosclerosis onset.

Authors:  Carmine Di Rienzo; Emanuela Jacchetti; Francesco Cardarelli; Ranieri Bizzarri; Fabio Beltram; Marco Cecchini
Journal:  Sci Rep       Date:  2013-01-25       Impact factor: 4.379

10.  6-Shogaol Protects against Oxidized LDL-Induced Endothelial Injruries by Inhibiting Oxidized LDL-Evoked LOX-1 Signaling.

Authors:  Yun Kai Wang; Ya Jun Hong; Yong Hua Yao; Xiao Min Huang; Xue Bo Liu; Chun Yu Zhang; Lei Zhang; Xiaoliang Leon Xu
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-19       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.